Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
Active, not recruiting · NCT04075981 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-07-01 | NCT04075981 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
| Merz Pharmaceuticals | 2 |
| Ministry of Health, France | 84 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Limoges | Limoges | France | 2 |
| Clinique Ambroise Paré | Neuilly-sur-Seine | France | 1 |
| Corentin Celton | Issy-les-Moulineaux | France | 1 |
| Hôpital Européen Georges Pompidou | Paris | France | 5 |
| Hôpital Marie Lannelongue | Le Plessis-Robinson | France | 1 |
| Hôpital Saint-Joseph | Marseille | France | 1 |
| Institut Mutualiste Montsouris | Paris | France | 1 |